USE OF CA-19-9 IN THE EARLY DETECTION OF RECURRENCES IN COLORECTAL-CANCER - COMPARISON WITH CEA

被引：46

作者：

FILELLA, X

MOLINA, R

PIQUE, JM

GARCIAVALDECASAS, JC

GRAU, JJ

NOVELL, F

ASTUDILLO, E

DELACY, A

DANIELS, M

BALLESTA, AM

机构：

[1] HOSP CLIN BARCELONA,DEPT GASTROENTEROL,BARCELONA,SPAIN

[2] HOSP CLIN BARCELONA,DEPT SURG,BARCELONA,SPAIN

[3] HOSP CLIN BARCELONA,DEPT ONCOL,BARCELONA,SPAIN

来源：

TUMOR BIOLOGY | 1994年 / 15卷 / 01期

关键词：

CA; 19-9; CEA; CANCER-ASSOCIATED ANTIGENS; COLORECTAL CANCER; FOLLOW-UP;

D O I：

10.1159/000217867

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The serum levels of CA 19-9 were determined in the follow-up of 370 patients with colorectal cancer and compared with CEA. An increase in CA 19-9 preceded clinical diagnosis of recurrence in 25% of 72 patients. The mean time between the rise in CA 19-9 and clinical diagnosis of relapse was 3.7 months (median 3). Sensitivity of CA 19-9 in the early diagnosis of recurrence was much lower than that obtained for CEA (75%). Only 1 patient had elevated CA 19-9 levels and normal CEA.

引用

页码：1 / 6

页数：6

共 50 条

[11] THE USE OF CEA AND CA 19-9 IN THE FOLLOW-UP AFTER CURATIVE RESECTION OF COLORECTAL-CANCER
STAPEL, A
FRANKE, U
PUTZKI, H
ZENTRALBLATT FUR CHIRURGIE, 1992, 117 (02): : 77 - 80
[12] COMPARISON OF DIAGNOSTIC USEFULNESS OF CA-50, CA-19-9 AND CEA IN EFFUSIONS
LEMBERGER, J
SKENDEROVIC, S
TOROK, T
LIBMAN, E
MARTON, B
VOJNIC, S
NOVAKOVIC, R
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1988, 14 (5-6): : 326 - 326
[13] COMPARISON OF CA-72-4, CA-19-9 AND CEA IN THE DIAGNOSIS AND MONITORING OF GASTRIC-CANCER
SAFI, F
KUHNS, V
BEGER, HG
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 1995, 10 (02): : 100 - 106
[14] EVALUATION OF CA 12-5 AS A TUMOR-MARKER FOR GASTRIC AND COLORECTAL-CANCER IN COMPARISON TO CEA AND CA 19-9
QUENTMEIER, A
SCHLAG, P
GEISEN, HP
SCHMIDTGAYK, H
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 1987, 13 (03): : 197 - 201
[15] EVALUATION OF CA 12-5 AS A TUMOR-MARKER FOR GASTRIC AND COLORECTAL-CANCER IN COMPARISON TO CEA AND CA 19-9
QUENTMEIER, A
SCHLAG, P
GEISEN, HP
SCHMIDTGAYK, H
MEDIZINISCHE KLINIK, 1986, 81 (06) : 199 - 201
[16] FOLLOW-UP OF COLORECTAL-CANCER RESECTED FOR CURE - AN EXPERIENCE WITH CEA, TPA, CA-19-9 ANALYSIS AND 2ND-LOOK SURGERY
FUCINI, C
TOMMASI, SM
ROSI, S
MALATANTIS, G
CARDONA, G
PANICHI, S
BETTINI, U
DISEASES OF THE COLON & RECTUM, 1987, 30 (04) : 273 - 277
[17] ROLE OF F(AB')2 ANTI-CEA IMMUNOSCINTIGRAPHY IN PRESTAGING AND EARLY DETECTION OF RECURRENCES IN COLORECTAL-CANCER
BUCCI, L
GENTILE, M
LASTORIA, S
SALVATORE, M
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 1986, 5 (04) : 427 - 430
[18] AN IMMUNOHISTOCHEMICAL COMPARISON OF CEA AND CA-19-9 IN PATIENTS WITH GASTROINTESTINAL TUMORS AND CORRELATION WITH HISTOLOGICAL GRADING AND CEA-CA-19-9 SERUM LEVELS
LORENZ, M
HERRMANN, G
BAUM, RP
SCHULTZ, M
HOR, G
HOTTENROTT, C
ENCKE, A
NUC COMPACT-EUROPEAN-AMERICAN COMMUNICATIONS IN NUCLEAR MEDICINE, 1987, 18 (02): : 102 - 108
[19] A PROTOCOL OF THE USE OF CEA IN COLORECTAL-CANCER
DOMINGUEZ, MJ
LAMIQUIZ, A
JOURNAL OF NUCLEAR MEDICINE AND ALLIED SCIENCES, 1990, 34 (04): : 115 - 118
[20] DETECTION OF CA-125, CA-19-9 AND CEA IN NORMAL AND PATHOLOGICAL TISSUE OF THE ADNEXA BY IMMUNHISTOCHEMISTRY
NEUNTEUFEL, W
BREITENECKER, G
GEBURTSHILFE UND FRAUENHEILKUNDE, 1988, 48 (05) : 334 - 337

← 1 2 3 4 5 →